Stockreport

NantHealth and NantOmics to Present Data on Three-Fold Overestimation of Tumor Mutation Burden Using Gene Panel vs Whole Exome at the American Society of Clinical Oncology (ASCO) 2018 Annu...

NantHealth, Inc.  (NH) 
Last nanthealth, inc. earnings: 11/7 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: nanthealth.com
PDF Results to be presented during the tumor biology session at the ASCO 2018 Annual Meeting CHICAGO--(BUSINESS WIRE)-- NantWorks, LLC today [Read more]